Recently, a number of studies demonstrated that SFRP2 is not only hypermethylated in CRC tissue, but also in a spectrum of biological tissues including blood and stools, suggesting that SFRP2 methylation might be a potential non-invasive biomarker for CRC screening [14,15,16]. The gene discussed is SFRP2; the disease is colorectal carcinoma.